Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Consider benefits and risks of new alopecia treatments for safety.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Looking at skin can help find and treat serious diseases early.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

A boy with toxic shock syndrome had severe heart rhythm problems but recovered with treatment.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The conclusion of the case is not provided in the summary.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.